KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Treasury Shares (2023)

Historic Treasury Shares for Arbutus Biopharma (ABUS) over the last 1 years, with Q4 2023 value amounting to $1.2 million.

  • Arbutus Biopharma's Treasury Shares changed N/A to $1.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2023, which is N/A changed from last year.
  • Arbutus Biopharma's Treasury Shares amounted to $1.2 million in Q4 2023.
  • Over the past 5 years, Arbutus Biopharma's Treasury Shares peaked at $1.2 million during Q4 2023, and registered a low of $1.2 million during Q4 2023.